Identify Clinical Conditions That Increase Circulating DNA Levels
This trial is active, not recruiting.
|Conditions||pregnancy, pulmonary embolism, myocardial infarction, autoimmune disease|
|Treatment||one time blood draw to look at patient's dna|
|Sponsor||University of Florida|
|Start date||October 2012|
|End date||July 2017|
|Trial size||130 participants|
|Trial identifier||NCT01815996, 407-2012|
The investigators are developing a test that is expected to measure the amount of radiation a patient has been exposed to after a nuclear bomb. The investigator will do this by measuring the DNA in the patients blood from cells killed by the radiation.
Many diseases and medical conditions can put DNA in the blood. The investigator needs to know how much DNA in order to better interpret our radiation detection test. Therefore, the investigator is collecting blood from several patients with different diseases or medical conditions and also healthy volunteers to measure their DNA content.
Patients that will be included in this study are pregnant women, patients who have suffered a pulmonary embolism within the past 48 hours, patients who have suffered from myocardial infarction in the past 48 hours, patients with autoimmune diseases and health patients.
|Observational model||case control|
Different diseases will be analysed for the levels of DNA circulating in the blood
time frame: blood will be tested up to 1 year after collection
Male or female participants from 18 years up to 80 years old.
- Patients must be adults in one of the following categories:
- Suffered a pulmonary embolism within the past 48 hours
- Myocardial infarction in the past 48 hours
- Diagnosed with an autoimmune disease
- Adults age 18-80
- Self-declared healthy adults
- Patients must be willing to undergo a blood draw
- Patients must provide study-specific informed consent prior to study entry
- Patients not meeting the above inclusion criteria
|Official title||Identify Clinical Conditions That Increase Circulating DNA Levels|
|Principal investigator||Paul Okunieff, MD|
|Description||The investigator will collect 8 mL (one and one half teaspoons) of blood one time only. The investigator may also collect the patient's past medical history, test results and disease treatment.|
Call for more information